Skip to main content
. 2023 Jan 16;21:991–1004. doi: 10.1016/j.csbj.2023.01.019

Table 2.

Selected epitopes for multi-epitope vaccine design.

Protein CTL epitopes
(% rank, IC 50, antigenicity, immunogenicity)
HTL epitopes
(IFN-γ inducing activity, antigenicity)
Linear B-cell epitopes
(ABCpred score, antigenicity)
EspA FIIDPTISA
(0.089, 17092.26, 1.261, 0.107)
DLTYIPVVGHALSAA
(0.009, 0.554)
YSEGAAAGTEDAERAP
(0.970, 1.195)
EspA TYIPVVGHAL
(0.101, 390.63, 0.500, 0.195)
ADGPVGAAAEQVGGQ
(0.110, 1.395)
EDAERAPVEADAGGGQ
(0.920, 1.640)
EspA / TTTKKYSEGAAAGTE
(0.010, 1.508)
/
Mpt63 IPGYPVAGQVW
(0.337, 416.95, 0.590, 0.033)
STGKIYFDVTGPSPT
(2.000, 0.823)
GQVWEATATVNAIRGS
(0.910, 0.466)
Mpt63 GPSPTIVAM
(0.030, 48.29, 1.149, 0.156)
/ /
LprA KSEDAKFVY
(0.070, 625.66, 1.288, 0.013),
DAKFVYVDGHLYSDL
(1.000, 0.403)
GGCSTEGDAGKASDTA
(0.930, 2.554)
LprA NKSEDAKFVY
(0.127, 980.34, 1.114, 0.027)
/ LVQIQIAPTKDTSVTL
(0.930, 0.851)
PPE18 VWGLTVGSW
(0.353, 747.23, 0.689, 0.008)
AAQVRVAAAAYETAY
(0.335, 0.642)
GARAGGGLSGVLRVPP
(0.840, 1.358)
PPE18 APAAAAQAV
(0.087, 11.84, 0.638, 0.052)
AMFGYAAATATATAT
(0.604, 0.748)
/
PPE18 TPAARALPL
(0.015, 6.38,0.434, 0.123)
QNGVRAMSSLGSSLG
(0.458, 0.523)
/
EsxA / EQQWNFAGIEAAASA
(2.000, 0.742)
GGSGSEAYQGVQQKWD
(0.860, 1.801)
EsxA / AGIEAAASAIQGNVT
(2.000, 0.937)
/
EsxB STNIRQAGVQY
(0.224, 1137.27, 1.111, 0.107)
AVVRFQEAANKQKQE
(0.230, 0.858)
LKTQIDQVESTAGSLQ
(0.860, 1.039)
EsxB / STNIRQAGVQYSRAD
(1.000, 0.999)
/
LppX VLDPAAGVTQL
(0.107, 4393.17, 0.426, 0.1090
QGVPFRVQGDNISVK
(0.385, 1.992)
SLLGITSADVDVRANP
(0.950, 1.206)
LppX HVAVRTTGK
(0.217, 38.73, 0.994, 0.194)
STTKITGTIPASSVK
(1.000, 0.529)
/
LppX RVQGDNISVK
(0.155, 237.77, 2.643, 0.021)
/ /
EspC SQFNDTLNV
(0.185, 38.23, 0.616, 0.076)
TAGVDLAKSLRIAAK
(0.030, 0.670)
AVDASSGVEAAAGLGE
(0.890, 1.188
EspC SLHTAGVDLAK
(0.385, 559.6, 1.024, 0.195)
RIAAKIYSEADEAWR
(0.027, 0.456)
/